Department of Animal Science, Sari Agricultural Sciences and Natural Resources University, Sari, Iran.
Department of Animal Science, Sari Agricultural Sciences and Natural Resources University, Sari, Iran.
Theriogenology. 2020 Jan 1;141:98-104. doi: 10.1016/j.theriogenology.2019.09.017. Epub 2019 Sep 10.
The objective was to evaluate the association between postpartum health disorders, reproductive responses and pregnancy status in lactating multiparous cyclic Holstein cows. Cows were retrospectively categorized as healthy (n = 70) or sick (n = 60) based on postpartum health records and serum metabolites. Sick cows were further categorized as having metabolic (MET; n = 35), infectious (INF; n = 15), or both diseases (MET/INF; n = 10). Blood samples were collected on d 7 and 14 after calving to determine serum concentrations non-esterified fatty acids (NEFA), β-hydroxybutyrate (BHB) and aspartate aminotransferase (AST), on d 0 (TAI), 8, 16, 18 and 20 after TAI to determine concentrations of progesterone (P4; d 0, 8, 16, 18 and 20) and prostaglandin F metabolite (PGFM; d 16, 18 and 20) and interferon-stimulated gene-15 (ISG15; d 16) relative mRNA expression. Cyclicity was determined by transrectal ultrasonography 30 d postpartum and cows were subjected to a GnRH-based TAI protocol (to classify cows bearing a visible CL as cyclic). Prediction of pregnancy status on d 16 after TAI was determined by ISG15 mRNA gene expression relative to β actin and following, pregnancy was diagnosed by transrectal ultrasonography at 32 and 60 d after TAI. An interaction (P = 0.04) between occurrence of disease and pregnancy status was detected for the expression of ISG15 in blood, with healthy pregnant healthy cows having the greatest relative expression of ISG15. Postpartum health disorders were associated with reduced concentration (P < 0.05) of serum P4 post TAI. However, serum P4 concentrations at TAI were greater (P = 0.01) in sick cows (0.65 ± 0.09, 0.86 ± 0.13 and 0.75 ± 0.10 ng/mL for MET, INF and MET/INF cows, respectively) compared with that in healthy cows (0.24 ± 0.10 ng/mL). Serum concentrations of PGFM after TAI was reduced in healthy cows, regardless of pregnancy status. Pregnancy status on d 16 after TAI predicted by ISG15 mRNA expression and P/AI on d 32 and 60 after TAI based on ultrasonography, were negatively affected (P < 0.05) by occurrence of health disorders. Similarly, pregnancy loss from d 16 to 32 and d 16 to 60 after TAI was greater (P < 0.05) in sick cows compared to that in healthy cows. However, neither P/AI nor pregnancy loss were associated to the category of postpartum health disorder. Cows affected by postpartum health disorders had overall reduced P4 and greater PGFM serum concentrations after TAI, which were associated with reduced pregnancy success and enhanced pregnancy loss. Collectively, our findings support the hypothesis of a carryover effect of disease on reproductive responses, embryo survival and maintenance of pregnancy in lactating dairy cows independent of the category of postpartum health disorder.
本研究旨在评估产后健康障碍、生殖反应和哺乳期多胎荷斯坦奶牛妊娠状态之间的关系。根据产后健康记录和血清代谢物,将奶牛分为健康(n=70)或患病(n=60)。患病奶牛进一步分为代谢(MET;n=35)、感染(INF;n=15)或同时患有两种疾病(MET/INF;n=10)。产后第 7 天和第 14 天分别采集血液样本,以确定血清中游离脂肪酸(NEFA)、β-羟丁酸(BHB)和天门冬氨酸氨基转移酶(AST)的浓度,产后第 0 天(TAI)、第 8、16、18 和 20 天分别采集血液样本,以确定孕酮(P4;第 0、8、16、18 和 20 天)和前列腺素 F 代谢物(PGFM;第 16、18 和 20 天)和干扰素刺激基因 15(ISG15;第 16 天)的浓度。产后第 30 天通过直肠超声检查确定奶牛的周期性,并对奶牛进行 GnRH 基础 TAI 方案(将可见 CL 的奶牛分类为周期性)。产后第 16 天通过 ISG15 mRNA 基因表达相对于β肌动蛋白来预测妊娠状态,随后在 TAI 后 32 和 60 天通过直肠超声诊断妊娠。在血液中,ISG15 的表达检测到疾病发生与妊娠状态之间存在相互作用(P=0.04),健康妊娠的健康奶牛的 ISG15 相对表达最大。产后健康障碍与 TAI 后血清 P4 浓度降低有关(P<0.05)。然而,患病奶牛的 TAI 血清 P4 浓度较高(P=0.01),分别为 MET、INF 和 MET/INF 奶牛的 0.65±0.09、0.86±0.13 和 0.75±0.10 ng/mL,而健康奶牛的血清 P4 浓度为 0.24±0.10 ng/mL。TAI 后血清 PGFM 浓度在健康奶牛中降低,无论其妊娠状态如何。产后第 16 天通过 ISG15 mRNA 表达预测的妊娠状态和 TAI 后第 32 天和第 60 天基于超声的 P/AI,均受到健康障碍发生的负面影响(P<0.05)。同样,TAI 后第 16 天至 32 天和第 16 天至 60 天的妊娠丢失在患病奶牛中也高于健康奶牛(P<0.05)。然而,P/AI 或妊娠丢失与产后健康障碍的类别无关。患有产后健康障碍的奶牛在 TAI 后总体上表现出较低的 P4 和较高的 PGFM 血清浓度,这与妊娠成功率降低和妊娠丢失增加有关。综上所述,我们的研究结果支持疾病对生殖反应、胚胎存活和哺乳期奶牛妊娠维持产生持续影响的假设,而与产后健康障碍的类别无关。